Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 108 of the 110 references it cites were found in a registry or an index.
Abstract
Intestinal dysbiosis is thought to be an important cause of disease progression and the gastrointestinal symptoms experienced in patients with inflammatory bowel disease (IBD). Inflammation appears to be a major contributor in perpetuating a dysregulated gut microbiota. Although current drug therapies can significantly induce and maintain disease remission, there is no cure for these diseases. Nevertheless, ongoing human studies investigating dietary fibre interventions may potentially prove to exert beneficial outcomes for IBD. Postulated mechanisms include direct interactions with the gut mucosa through immunomodulation, or indirectly through the microbiome. Component species of the microbiome may degrade dietary-fibre polysaccharides and ferment the products to form short-chain fatty acids such as butyrate. Prebiotic dietary fibres may also act more directly by altering the composition of the microbiome. Longer term benefits in reducing the risk of more aggressive disease or colorectal cancer may require other dietary fibre sources such as wheat bran or psyllium. By critically examining clinical trials that have used dietary fibre supplements or dietary patterns containing specific types or amounts of dietary fibres, it may be possible to assess whether varying the intake of specific dietary fibres may offer an efficient treatment for IBD patients.
Overview
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
Citations
Cites
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,667 · cited 1×
“Various prebiotic DFs have been found to have this activity [95].”
BackgroundHost–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 1×
“Besides the role of genetic predisposition in the development of IBD [9], diet”
BackgroundSelf-citationSokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 2×
“prausnitzii has been correlated to protecting patients from IBD and a higher proportion of this bacterium in the gut microbiota tends to associate with disease remission [92,93].”
Background(1992) · PubMed · Cited by 3,809
Evolution of mammals and their gut microbes
Ley, R. E., Hamady, M., Lozupone, C., Turnbaugh, P. J., Ramey, R. R., Bircher, J. S., Schlegel, M. L., Tucker, T. A., Schrenzel, M. D., Knight, R., et al. (2008) · Science · doi:10.1126/science.1155725 · Cited by 3,747
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi-Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,553 · cited 1×
“Certain bacterial species, including Bifidobacteria and Faecalibacterium prausnitzii, have been shown to cause immunoregulatory effects following activation of dendritic cells that recognise bacteria in the intestinal microbiota, using pattern recognition receptors such as toll-like receptors (TLRs) that bind to disti…”
BackgroundInflammatory bowel disease: clinical aspects and established and evolving therapies
Baumgart, D. C., & Sandborn, W. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60751-x · Cited by 1,920 · cited 1×
“Furthermore, IBD complications that can arise are an obstructed bowel and the passing of mucus, pus or blood [6,7].”
BackgroundIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 1×
“Another difference observed in patients with intestinal inflammation compared with healthy individuals is an impaired intestinal barrier thought to be controlled by diet and bacterial species residing in the gut microbiota [94].”
BackgroundDysbiosis of the gut microbiota in disease
Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., & Owen, L. J. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26191 · Cited by 1,710 · cited 1×
“As well as modulating inflammation, there is also evidence that intestinal dysbiosis is involved with the development of colorectal cancer in IBD patients [62].”
BackgroundPotential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
Faecalibacterium prausnitzii and human intestinal health
Miquel, S., Martín, R., Rossi, O., Bermúdez-Humarán, L., Chatel, J., Sokol, H., Thomas, M., Wells, J., & Langella, P. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.003 · Cited by 1,228
Defining dysbiosis and its influence on host immunity and disease
Petersen, C., & Round, J. L. (2014) · Cellular Microbiology · doi:10.1111/cmi.12308 · Cited by 1,170 · cited 1×
“It is defined by a predominance of potentially beneficial species being found in stool samples, primarily belonging to Firmicutes and Bacteriodes, but usually also with minor amounts of Protobacteria and Actinobacteria [19,20].”
BackgroundBrewers' spent grain: generation, characteristics and potential applications
Mussatto, S. I., Dragone, G., & Roberto, I. C. (2006) · Journal of Cereal Science · doi:10.1016/j.jcs.2005.06.001 · Cited by 1,086
Towards a more comprehensive concept for prebiotics
Bindels, L. B., Delzenne, N. M., Cani, P. D., & Walter, J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.47 · Cited by 914 · cited 1×
“More recent arguments have been advanced, indicating that recent advances in our understanding of diet–microbiome–host interactions challenge this older concept, especially the requirement for effects to be “selective” or “specific” [66].”
BackgroundInulin-Type Fructans: Functional Food Ingredients
Roberfroid, M. B. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.11.2493s · Cited by 878 · cited 1×
“Thus, although usually regarded as oligosaccharides, technically the molecules range from oligosaccharides to small polysaccharides, with the molecules with DPs of 2–9 being referred to as oligofructoses (or fructo-oligosaccharides), and those with DPs of 10 and greater as high molecular weight inulin [59,60].”
BackgroundCleynen, I., Boucher, G., Jostins, L., Schumm, L. P., Zeissig, S., Ahmad, T., Andersen, V., Andrews, J. M., Annese, V., Brand, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00465-1 · Cited by 779 · cited 1×
“Although CD has been traditionally defined as a chronic inflammatory condition that can be located anywhere on the epithelial layer of the gastrointestinal tract (GIT) [3,4], a recent analysis suggests that CD might itself be divided into two classes, depending partly on the disease location [5].”
BackgroundSelf-citationTibble, J. A., Sigthorsson, G., Bridger, S., Fagerhol, M. K., & Bjarnason, I. (2000) · Gastroenterology · doi:10.1053/gast.2000.8523 · Cited by 759 · cited 2×
“Furthermore, other outcomes associated with other types of DF may aid in diminishing the risk for subsequent clinical relapses [83,84].”
BackgroundEvidence‐based dietary management of functional gastrointestinal symptoms: The FODMAP approach
Gibson, P. R., & Shepherd, S. J. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06149.x · Cited by 654 · cited 3×
“This speeds their movement into the large intestine where they are rapidly degraded and fermented [61].”
BackgroundIntestinal permeability and the prediction of relapse in Crohn's disease
Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90882-h · Cited by 626 · cited 2×
“Furthermore, other outcomes associated with other types of DF may aid in diminishing the risk for subsequent clinical relapses [83,84].”
BackgroundModulation of human dendritic cell phenotype and function by probiotic bacteria
Hart, A. L., Lammers, K., Brigidi, P., Vitali, B., Rizzello, F., Gionchetti, P., Campieri, M., Kamm, M. A., Knight, S. C., & Stagg, A. J. (2004) · Gut · doi:10.1136/gut.2003.037325 · Cited by 555 · cited 1×
“activity can cause an increase in DC IL-10 stimulated release and reduce interferon-γ (IFN-γ) production by activated CD4+ T cells [91] whereas Faecalibacterium prausnitzii can increase IL-10 production and decrease peripheral blood IL-12 levels, at least in human in vitro experiments [92].”
BackgroundLindsay, J. O. (2006) · Gut · doi:10.1136/gut.2005.074971 · Cited by 471 · cited 14×
“Active CD patients [40] Chicory fructans as Prebio 1 ® (Nestlé, Vevey, Switzerland), 15 g/day, 3 weeks Total = 10 HBI, CDAI scores, serum CRP, full blood count, faecal and mucosal biopsy measurements Ò faecal Bifidobacterium”
BackgroundInfluentialWheat bran: Its composition and benefits to health, a European perspective
Stevenson, L., Phillips, F., O'sullivan, K., & Walton, J. (2012) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2012.687366 · Cited by 459 · cited 1×
“Wheat bran is known to consist of ~46% non-starch polysaccharides (NSP) from arabinoxylans, cellulose, and 1,3;1,4-β-glucans [103].”
BackgroundCODEX-aligned dietary fiber definitions help to bridge the ‘fiber gap’
Jones, J. M. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-34 · Cited by 422
The physiological roles of dietary fibre
Brownlee, I. A. (2011) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2009.11.013 · Cited by 417
Multifunctional fructans and raffinose family oligosaccharides
Ende, W. V. D. (2013) · Frontiers in Plant Science · doi:10.3389/fpls.2013.00247 · Cited by 398
Fernández-Bañares, F. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00753-9 · Cited by 385
Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches
Papadimitriou, K., Zoumpopoulou, G., Foligné, B., Alexandraki, V., Kazou, M., Pot, B., & Tsakalidou, E. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00058 · Cited by 384
The gel-forming polysaccharide of psyllium husk (Plantago ovata Forsk)
Fischer, M. H., Yu, N., Gray, G. R., Ralph, J., Anderson, L., & Marlett, J. A. (2004) · Carbohydrate Research · doi:10.1016/j.carres.2004.05.023 · Cited by 366
Benjamin, J. L., Hedin, C. R. H., Koutsoumpas, A., Ng, S. C., McCarthy, N. E., Hart, A. L., Kamm, M. A., Sanderson, J. D., Knight, S. C., Forbes, A., et al. (2011) · Gut · doi:10.1136/gut.2010.232025 · Cited by 361 · cited 11×
“Active CD patients [2] Chicory fructan as Synergy 1 (Beneo Orafti, Belgium), 15 g/day, RCT (DB)/4 weeks Total = 103 CDAI, IBDQ, serum CRP, ESR, platelet count, and faecal calprotectin measurements Ó disease activity”
BackgroundInfluentialVivinus-Nébot, M., Frin-Mathy, G., Bzioueche, H., Dainese, R., Bernard, G., Anty, R., Filippi, J., Saint-Paul, M. C., Tulic, M. K., Verhasselt, V, et al. (2014) · Gut · doi:10.1136/gutjnl-2012-304066 · Cited by 348 · cited 1×
“Inflammatory bowel disease (IBD) are a group of gastrointestinal disorders characterised by chronic inflammation and dysbiosis of the gut microbiota [1,2].”
BackgroundThe Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Irrazábal, T., Belcheva, A., Girardin, S. E., Martin, A., & Philpott, D. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.039 · Cited by 344 · cited 1×
“Links have been postulated between the intestinal dysbiosis that occurs in IBD and inflammatory processes, but whether one factor is a consequence of the other is unclear [87].”
BackgroundThe dynamics of gut‐associated microbial communities during inflammation
Winter, S. E., Lopez, C. A., & Bäumler, A. J. (2013) · EMBO reports · doi:10.1038/embor.2013.27 · Cited by 329 · cited 1×
“However in IBD patients exhibiting chronic inflammation in the gut, this microbial composition is altered and the presence of potentially pathogenic microorganisms tends to be a prominent contributor of intestinal dysbiosis [86].”
BackgroundGearry, R. B., Irving, P. M., Barrett, J. S., Nathan, D. M., Shepherd, S. J., & Gibson, P. R. (2009) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2008.09.004 · Cited by 322 · cited 2×
“Two single-arm intervention studies lasting six weeks and three months, respectively, investigated a low-FODMAP diet, mainly in patients with IBD and one with chronic constipation [77,78].”
Background(2016) · PubMed · Cited by 287
Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention
Zeng, H. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i2.41 · Cited by 266 · cited 1×
“Potential benefits include reducing diarrhoea or constipation, producing short-chain fatty acids (SCFAs), down-regulating inflammation, promoting tissue healing, and by these means potentially preventing the onset of colorectal cancer (CRC) in susceptible IBD patients [25–29].”
BackgroundLecerf, J.-M., Dépeint, F., Clerc, E., Dugenet, Y., Niamba, C. N., Rhazi, L., Cayzeele, A., Abdelnour, G., Jaruga, A., Younes, H., et al. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511007252 · Cited by 262 · cited 2×
“As a result, bacterial secretion of cytokines stimulates corresponding T-cell responses such as Th1 (pro-inflammatory), Th2 or Treg (both anti-inflammatory) pathways [90].”
BackgroundCASELLAS, F., BORRUEL, N., TORREJÓN, A., VARELA, E., ANTOLIN, M., GUARNER, F., & MALAGELADA, J. ‐. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03288.x · Cited by 259 · cited 4×
“found that patients recorded a reduction in dyspeptic symptoms, and the level of the faecal inflammatory biomarker, calprotectin, had decreased by day 7 of the intervention period [42].”
BackgroundMethodInfluentialRaninen, K., Lappi, J., Mykkänen, H., & Poutanen, K. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00358.x · Cited by 254 · cited 1×
“Potential benefits include reducing diarrhoea or constipation, producing short-chain fatty acids (SCFAs), down-regulating inflammation, promoting tissue healing, and by these means potentially preventing the onset of colorectal cancer (CRC) in susceptible IBD patients [25–29].”
BackgroundCROHN'S DISEASE: MAINTENANCE OF REMISSION BY DIET
Jones, V. A., Workman, E., Freeman, A. H., Dickinson, R. J., Wilson, A. J., & Hunter, J. O. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91497-7 · Cited by 244 · cited 5×
“Jones and co-workers designed an RCT in which a DF-rich, unrefined carbohydrate diet was compared with an exclusion diet, individually tailored to the patient [32].”
BackgroundMethodResultInfluentialMcCleary, B. V., DeVries, J. W., Rader, J. I., Cohen, G., Prosky, L., Mugford, D. C., Champ, M., & Okuma, K. (2012) · Journal of AOAC INTERNATIONAL · doi:10.5740/jaoacint.cs2011_25 · Cited by 235 · cited 1×
“25 [46].”
The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria
Stagg, A. J., Hart, A. L., Knight, S. C., & Kamm, M. A. (2003) · Gut · doi:10.1136/gut.52.10.1522 · Cited by 234 · cited 1×
“Certain bacterial species, including Bifidobacteria and Faecalibacterium prausnitzii, have been shown to cause immunoregulatory effects following activation of dendritic cells that recognise bacteria in the intestinal microbiota, using pattern recognition receptors such as toll-like receptors (TLRs) that bind to disti…”
BackgroundEffects of dietary fiber on inflammatory bowel disease
Galvez, J., Rodríguez‐Cabezas, M. E., & Zarzuelo, A. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500013 · Cited by 231 · cited 1×
“SCFAs act as a fuel source for colonocytes and have been suggested to modulate inflammation in the intestine by enhancing the proportion of non-pathogenic microbes in the gut microbiota [97].”
BackgroundLifestyle-related disease in Crohn’s disease: Relapse prevention by a semi-vegetarian diet
Chiba, M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i20.2484 · Cited by 230 · cited 8×
“C-reactive protein (CRP) is measured from serum, and provides a general and very sensitive measure of systemic inflammation, albeit not specific to the GI tract (GIT) [40,41].”
BackgroundInfluentialIncreasing Fecal Butyrate in Ulcerative Colitis Patients by Diet: Controlled Pilot Study
Hallert, C., Björck, I., Nyman, M., Pousette, A., Grännö, C., & Svensson, H. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200303000-00005 · Cited by 228 · cited 9×
“The concentrations of faecal SCFAs such as butyrate have also been used as an endpoint [21,37].”
BackgroundMethodInfluentialMILLARD, A. L., MERTES, P. M., ITTELET, D., VILLARD, F., JEANNESSON, P., & BERNARD, J. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.0009-9104.2002.01977.x · Cited by 220 · cited 1×
“In addition, butyrate can alter the maturation of dendritic cells and induce the production of anti-inflammatory cytokines that favour dendritic cell-secretion of IL-10 and its activity in vitro [100].”
BackgroundConverging goals of treatment of inflammatory bowel disease from clinical trials and practice
Levesque, B. G., Sandborn, W. J., Ruel, J., Feagan, B. G., Sands, B. E., & Colombel, J.-F. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.08.003 · Cited by 217 · cited 2×
“It is apparent that CDAI scores are weighted based on symptoms experienced and a score of <150 implies clinical remission in patients with CD [38].”
BackgroundImpact of Diet on Human Intestinal Microbiota and Health
Salonen, A., & de Vos, W. M. (2014) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030212-182554 · Cited by 215 · cited 1×
“Bile acids are critical for the digestion and absorption of fats and fat-soluble vitamins in the small intestine, and may indirectly help to shape the gut microbiota [74].”
BackgroundDiet and Inflammatory Bowel Disease: Review of Patient-Targeted Recommendations
Hou, J. K., Lee, D., & Lewis, J. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.063 · Cited by 202 · cited 1×
“However, the low-FODMAP diet which reduces or eliminates such molecules is claimed to have produced favourable outcomes for IBD patients [61,101].”
BackgroundKanauchi, O., Suga, T., Tochihara, M., Hibi, T., Naganuma, M., Homma, T., Asakura, H., Nakano, H., Takahama, K., Fujiyama, Y., et al. (2002) · Journal of Gastroenterology · doi:10.1007/bf03326417 · Cited by 194 · cited 11×
“C-reactive protein (CRP) is measured from serum, and provides a general and very sensitive measure of systemic inflammation, albeit not specific to the GI tract (GIT) [40,41].”
BackgroundMethodInfluentialPlantago - viel mehr als nur ein Stuhlregulans
Bachmann, C. (2014) · Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine · doi:10.1159/000362776 · Cited by 194
Diet and risk of inflammatory bowel disease
Andersen, V. C., Olsen, A., Carbonnel, F., Tjønneland, A. M., & Vogel, U. B. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.10.001 · Cited by 176 · cited 1×
“Therefore, it has been suggested that nutritional therapy can be aimed at reducing gut inflammation and consequently helping to prevent relapse [13–15].”
BackgroundMcCleary, B. V., De Vries, J. W., Rader, J. I., Cohen, G., Prosky, L., Mugford, D. C., Champ, M., Okuma, K., Collaborators:, Abercrombie, L., et al. (2010) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/93.1.221 · Cited by 169 · cited 1×
“01 [45], and a version of the method that measures both soluble and insoluble DF referred to as AOAC Official Method 2011.”
MethodInflammatory bowel disease: role of diet, microbiota, life style
Neuman, M. G., & Nanau, R. M. (2012) · Translational Research · doi:10.1016/j.trsl.2011.09.001 · Cited by 168
Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet.
Heaton, K. W., Thornton, J. R., & Emmett, P. M. (1979) · BMJ · doi:10.1136/bmj.2.6193.764 · Cited by 163 · cited 5×
“Early studies with diets described as DF-rich, unrefined-carbohydrate diets gave apparently different results [30,32].”
BackgroundResultInfluentialIspaghula Husk May Relieve Gastrointestinal Symptoms in Ulcerative Colitis in Remission
Hallert, C., Kaldma, M., & Petersson, B. G. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529108998594 · Cited by 146 · cited 5×
“found an overall benefit in patients with inactive UC from consuming psyllium husk or seeds [33,71].”
BackgroundMethodInfluentialSignificance of Inulin Fructans in the Human Diet
Schaafsma, G., & Slavin, J. L. (2015) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12119 · Cited by 131 · cited 1×
“Thus, although usually regarded as oligosaccharides, technically the molecules range from oligosaccharides to small polysaccharides, with the molecules with DPs of 2–9 being referred to as oligofructoses (or fructo-oligosaccharides), and those with DPs of 10 and greater as high molecular weight inulin [59,60].”
BackgroundRole of nutrition and microbiota in susceptibility to inflammatory bowel diseases
Gentschew, L., & Ferguson, L. R. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100630 · Cited by 129 · cited 1×
“Nutritional therapy may also act indirectly, through effects on the colonic microbiome [16].”
BackgroundSelf-citationSoluble Fiber Polysaccharides: Effects on Plasma Cholesterol and Colonic Fermentation
Topping, D. L. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1991.tb03021.x · Cited by 129 · cited 1×
“This has been demonstrated to occur with a soluble pectin preparation that was degraded almost fully and mostly in the proximal colon [56].”
BackgroundMehmood, M. H., Aziz, N., Ghayur, M. N., & Gilani, A. H. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1466-0 · Cited by 126
Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients.
Levenstein, S., Prantera, C., Luzi, C., & D'Ubaldi, A. (1985) · Gut · doi:10.1136/gut.26.10.989 · Cited by 122 · cited 3×
“The low-residue diet used in the RCT of CD patients had no significantly different outcomes as compared with that of the normal Italian diet [79].”
BackgroundMethodResultInfluentialAbnormal fibre usage in UC in remission
James, S. L., Christophersen, C. T., Bird, A. R., Conlon, M. A., Rosella, O., Gibson, P. R., & Muir, J. G. (2015) · Gut · doi:10.1136/gutjnl-2014-307198 · Cited by 121 · cited 9×
“C-reactive protein (CRP) is measured from serum, and provides a general and very sensitive measure of systemic inflammation, albeit not specific to the GI tract (GIT) [40,41].”
BackgroundMethodInfluentialProtection against cancer by wheat bran
Ferguson, L. R., & Harris, P. J. (1999) · European Journal of Cancer Prevention · doi:10.1097/00008469-199902000-00003 · Cited by 115 · cited 1×
“Wheat bran also has a number of associated phytochemicals, which may augment the effects of the DF [105].”
BackgroundSelf-citationButyrate esterified to starch is released in the human gastrointestinal tract
Clarke, J. M., Topping, D. L., Christophersen, C. T., Bird, A. R., Lange, K. M., Saunders, I. W., & Cobiac, L. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.017228 · Cited by 113 · cited 1×
“Butyrate can exert anti-inflammatory and anti-carcinogenic effects to the host through epigenetic modifications associated with the inhibition of histone deacetylases [98,99].”
BackgroundTreatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study
Mitsuyama, Saiki, Kanauchi, Iwanaga, Tomiyasu, Nishiyama, Tateishi, Shirachi, Ide, Suzuki, et al. (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00432.x · Cited by 112 · cited 3×
“Active UC patients [34] Germinated barley foodstuff, 30 g/3 times daily, Pilot 4 weeks Total = 10 CAI score, endoscopic index, serum CRP, ESR, and stool SCFA measurements Clinical and endoscopic improvements”
BackgroundJoossens, M., De Preter, V., Ballet, V., Verbeke, K., Rutgeerts, P., & Vermeire, S. (2012) · Gut · doi:10.1136/gutjnl-2011-300413 · Cited by 111 · cited 2×
“Inactive and active CD patients [69] Chicory fructan as Sygergy 1), 10 g/2 times daily, RCT (DB)/4 weeks Total = 45”
BackgroundDe Preter, V., Joossens, M., Ballet, V., Shkedy, Z., Rutgeerts, P., Vermeire, S., & Verbeke, K. (2013) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2012.24 · Cited by 108 · cited 10×
“The pilot double-blinded RCT with four weeks of daily intake of Synergy 1® found relatively increased levels of acetaldehyde and butyrate compared to baseline in the patients [21].”
BackgroundMethodInfluentialTriggs, C. M., Munday, K., Hu, R., Fraser, A. G., Gearry, R. B., Barclay, M. L., & Ferguson, L. R. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.01.020 · Cited by 107 · cited 3×
“Diet and genetic susceptibility are also known to influence the development of this condition [23].”
BackgroundSelf-citationTherapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches
Hansen, J. J., & Sartor, R. B. (2015) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0042-7 · Cited by 104 · cited 1×
“Various microbial-directed therapies have been proposed, including faecal microbial transplant, antibiotics, probiotics, and prebiotics [63,64].”
BackgroundDietary fibres may protect or enhance carcinogenesis
Harris, P. J., & Ferguson, L. R. (1999) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5742(99)00013-7 · Cited by 99 · cited 1×
“We have also reported that wheat bran is able to protect against colon cancer [28,29].”
BackgroundSelf-citationCroagh, C., Shepherd, S. J., Berryman, M., Muir, J. G., & Gibson, P. R. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20249 · Cited by 99
Role of diet in the management of inflammatory bowel disease
Rajendran, N. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i12.1442 · Cited by 98 · cited 1×
“Therefore, it has been suggested that nutritional therapy can be aimed at reducing gut inflammation and consequently helping to prevent relapse [13–15].”
BackgroundFermentation of non-digestible oligosaccharides by human colonic bacteria
Gibson, G. R., Willems, A., Reading, S., & COLLINS, M. D. (1996) · Proceedings of The Nutrition Society · doi:10.1079/pns19960087 · Cited by 89 · cited 1×
“One of the more attractive strategies for modulating the gut microbiota is prebiotics, which were originally defined as “selectively fermented non-digestible food ingredients or substances that specifically support the growth and/or activity of health-promoting bacteria that colonize the gastrointestinal tract” [65].”
BackgroundKanauchi, O., & Agata, K. (1997) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.61.29 · Cited by 80 · cited 1×
“This is known as germinated barley foodstuff and is generated by wet grinding followed by sieving [52].”
BackgroundChemoprevention of Cancer and DNA Damage by Dietary Factors
(2009) · Wiley eBooks · doi:10.1002/9783527626588 · Cited by 80
The dietary fibre debate: more food for thought
Ferguson, L. R., & Harris, P. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13219-9 · Cited by 78 · cited 1×
“We have also reported that wheat bran is able to protect against colon cancer [28,29].”
BackgroundSelf-citationBrotherton, C. S., Taylor, A. G., Bourguignon, C., & Anderson, J. G. (2014) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000047 · Cited by 78
Charlebois, A., Rosenfeld, G., & Bressler, B. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2012.760515 · Cited by 71 · cited 1×
“Diets low in DF (low residue diets) are sometimes recommended to patients with the active forms of the diseases [22], while recommendations for patients with the inactive forms have usually not considered dietary fibre, partly because individuals differ in dietary tolerances and intolerances [23,24].”
BackgroundDavies, P. S., & Rhodes, J. (1978) · BMJ · doi:10.1136/bmj.1.6126.1524 · Cited by 70
Advances in the treatment of Crohn’s disease
Egan, L. J., & Sandborn, W. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.062 · Cited by 65 · cited 2×
“Directing th therapeutic objective of DF intervention to aid in the m dification of the micr biota composition in the inflamed gastrointestinal tract in IBD pat ents may indirectly improve its immunologic function nd modify the disease course over the lo g term [80–82].”
BackgroundFaghfoori, Z., Shakerhosseini, R., Navai, L., Somi, M. H., Nikniaz, Z., & Abadi, A. (2014) · Europe PMC (PubMed Central) · doi:10.5681/hpp.2014.015 · Cited by 51
Alles, M. S., Katan, M., Salemans, J., Laere, K. V., Gerichhausen, M. J. W., Rozendaal, M., & Nagengast, F. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.5.1286 · Cited by 50 · cited 3×
“The trial compared the effects of three seven-day supplement periods of fructans (oligofructoses as Raftilose P95®), RS and digestible carbohydrate intake with seven-day washout periods between them with a glucose placebo [67].”
BackgroundMethodAnderson, J. E., Hedin, C. R. H., Benjamin, J. L., Koutsoumpas, A. L., Ng, S. C., Hart, A. L., Forbes, A., Stagg, A. J., Lindsay, J. O., & Whelan, K. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv136 · Cited by 48 · cited 1×
“A case-controlled observational study (not included in the tables since no dietary changes were involved) compared the habitual intake of fructans of both inactive and active CD patients to the intake of healthy controls [70].”
BackgroundJoossens, M., Huys, G., Van Steen, K., Cnockaert, M., Vermeire, S., Rutgeerts, P., Verbeke, K., Vandamme, P., & De Preter, V. (2011) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2010.01008.x · Cited by 44
High Calorie Diet and the Human Brain: Metabolic Consequences of Long-Term Consumption
Farooqui, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-15254-7 · Cited by 40
Mucosal Healing in Pediatric Crohnʼs Disease
D’Haens, G. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200407000-00024 · Cited by 37 · cited 2×
“Directing th therapeutic objective of DF intervention to aid in the m dification of the micr biota composition in the inflamed gastrointestinal tract in IBD pat ents may indirectly improve its immunologic function nd modify the disease course over the lo g term [80–82].”
BackgroundChemoprevention of cancer and DNA damage by dietary factors
Gerscher, A. J. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70153-6 · Cited by 34
Berghouse, L., Hori, S., Hill, M. J., Hudson, M., Lennard‐Jones, J. E., & Rogers, E. (1984) · Gut · doi:10.1136/gut.25.10.1071 · Cited by 32
Distribution, Fine Structure and Function of (1,3;1,4)-β-Glucans in the Grasses and Other Taxa
Harris, P. J., & Fincher, G. B. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373971-1.00021-2 · Cited by 31
Self-citationBiomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review
Murdoch, T. B., O’Donnell, S., Silverberg, M. S., & Panaccione, R. (2015) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2015/389548 · Cited by 30 · cited 2×
“Biomarkers are defined as “measureable substances derived from a biofluid or tissue specimens” [39].”
BackgroundCell-wall Polysaccharides of Potatoes
Harris, P. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374349-7.00003-9 · Cited by 29 · cited 1×
“In addition, small proportions of lignin are present in the outer layers of some brans, particularly wheat bran [27,47–49].”
BackgroundSelf-citationZhang, Y. (2008) · Sage eBooks · doi:10.4135/9781412963855.n627 · Cited by 26
Enteral Nutrition in Crohn Disease: More Than Just Calories
Heuschkel, R. B. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200403000-00002 · Cited by 21 · cited 2×
“Directing th therapeutic objective of DF intervention to aid in the m dification of the micr biota composition in the inflamed gastrointestinal tract in IBD pat ents may indirectly improve its immunologic function nd modify the disease course over the lo g term [80–82].”
BackgroundHerfarth, H., & Rogler, G. (2005) · Endoscopy · doi:10.1055/s-2004-826083 · Cited by 19
Importance and Roles of Fiber in the Diet
Farooqui, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-15254-7_7 · Cited by 18
Metagenomics of the human intestinal tract: from who is there to what is done there
Cultrone, A., Tap, J., Lapaque, N., Dore, J. M., & Blottière, H. M. (2015) · Current Opinion in Food Science · doi:10.1016/j.cofs.2015.05.011 · Cited by 16 · cited 1×
“When functioning optimally, this is actively involved in nutrient metabolism, energy homeostasis and regulates immune responses, protecting the GI tract from harmful dietary pathogens [17,18].”
BackgroundInflammatory Bowel Disease: Current Concepts in Pathogenesis and Therapy
Gibson, P. R. (1994) · BioDrugs · doi:10.1007/bf03259263 · Cited by 16
Marlow, G., Han, D. Y., Triggs, C. M., & Ferguson, L. R. (2015) · Lifestyle Genomics · doi:10.1159/000435783 · Cited by 15 · cited 3×
“Diets low in DF (low residue diets) are sometimes recommended to patients with the active forms of the diseases [22], while recommendations for patients with the inactive forms have usually not considered dietary fibre, partly because individuals differ in dietary tolerances and intolerances [23,24].”
BackgroundSelf-citationFerguson, L. R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00467 · Cited by 15
Self-citationBasics in Clinical Nutrition: Nutritional support in inflammatory bowel disease
Lochs, H. H. (2009) · e-SPEN the European e-Journal of Clinical Nutrition and Metabolism · doi:10.1016/j.eclnm.2009.06.009 · Cited by 14
Basford, P. J., Longcroft‐Wheaton, G., & Bhandari, P. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.05.039 · Cited by 14 · cited 2×
“It allows an initial diagnosis, distinguishing CD from UC, assessing disease extent and activity, monitoring response to therapy and surveying for dysplasia [35].”
BackgroundDietary Fiber Information for Individuals With Crohn Disease: Reports of Gastrointestinal Effects
Brotherton, C., & Taylor, A. G. (2013) · Gastroenterology Nursing · doi:10.1097/sga.0b013e3182a67a9a · Cited by 12 · cited 2×
“An interview-based single-arm study of wheat bran (WB) intake for four weeks found that CD patients perceived symptomatic benefits that included reductions in diarrhoea, pain and cramps, urgency and incontinence, and borborygmus (stomach gurgling) [75].”
BackgroundEjderhamn, J., Hedenborg, G., & Strandvik, B. (1992) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519209115515 · Cited by 10
What is known about the mechanisms of dietary influences in Crohn's disease?
Chan, D., Kumar, D., & Mendall, M. (2015) · Nutrition · doi:10.1016/j.nut.2015.04.018 · Cited by 9
The Changing Epidemiology of Inflammatory Bowel Disease: Identifying New High-risk Populations
de Silva, P. S., & Korzenik, J. R. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.022 · Cited by 8 · cited 1×
“Although pharmaceutical approaches to disease control have improved in recent years, there is still a high frequency of patients who are refractory to current drugs, including both conventional and biological therapies [8].”
BackgroundSuzuki, Y., Iida, M., Ito, H., Saida, I., & Hibi∥, T. (2016) · Intestinal Research · doi:10.5217/ir.2016.14.1.50 · Cited by 8 · cited 1×
“Mesalamine is a 5-amino-salicylate with general anti-inflammatory effects, often used as front-line therapy in UC [72].”
BackgroundWheat and Rice Dietary Fiber in Colorectal Cancer Prevention and the Maintenance of Health
Harris, P. J., & Ferguson, L. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-401716-0.00016-7 · Cited by 5
Self-citationDietary Fiber Carbohydrates and their Fermentation Products
Ferguson, L. R., & Harris, P. J. (2009) · Wiley eBooks · doi:10.1002/9783527626588.ch39 · Cited by 2 · cited 1×
“Four types of resistant starch (RS1–4) are often recognized [47].”
BackgroundSelf-citationGibson, P. R., & Iser, J. H. (2005) · PubMed · Cited by 2
Research works printed but not linked: 4
- Watson, R., Preedy, V., and Zibadi, S. (2014). Wheat and Rice in Disease Prevention and Health: Benefits, Risks, and Mechanisms of Whole Grains in Health Promotion, Academic Press.
- Singh, J., and Kaur, L. (2009). Advances in Potato Chemistry and Technology, Academic Press.
- Ralph, J., Brunow, G., and Boerjan, W. (2007). Encyclopedia of Life Sciences, John Wiley & Sons.
- Harris, P.J., and Fincher, G.B. (2009). Chemisty, Biochemistry, and Biology of the (1,3)-β-d-Glucans and Related Polysaccharides, Academic Press.
Cited by
The Health Benefits of Dietary Fibre
Barber, T. M., Kabisch, S., Pfeiffer, A. F. H., & Weickert, M. O. (2020) · Nutrients · doi:10.3390/nu12103209 · Cited by 892
“Signalling pathways that implicate nuclear factor kappa-B (NF-kB) and inhibition of deacetylase influence inflammatory processes both locally (including gut-wall leakiness and colonic inflammation in patients with inflammatory bowel disease [68]) and systemically, and both are likely influenced by levels of butyrate w…”
BackgroundDiet as a Trigger or Therapy for Inflammatory Bowel Diseases
Lewis, J. D., & Abreu, M. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.019 · Cited by 375
Roy, S., & Dhaneshwar, S. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i14.2078 · Cited by 334
Niu, W., Chen, X., Xu, R., Dong, H., Yang, F., Wang, Y., Zhang, Z., & Ju, J. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117189 · Cited by 237
Korcz, E., Kerényi, Z., & Varga, L. (2018) · Food & Function · doi:10.1039/c8fo00118a · Cited by 222
Metadata
- Authors
- Wong, C., Harris, P., & Ferguson, L.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Ferguson, Lynnette
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2016-06-14
- Volume
- 17
- Issue
- 6
- Pages
- 919
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC4926452
- OpenAlex
- W2438382511
- Cited by
- 116
- References
- 110
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 6 · 2023: 11 · 2022: 26 · 2021: 12 · 2020: 19 · 2019: 7 · 2018: 14 · 2017: 6 · 2016: 2
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ResearchSpace (University of Auckland) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Keywords
- dietary fiber, inflammatory bowel disease, gut dysbiosis, gut microbiota, short-chain fatty acids, butyrate, prebiotics, immunomodulation, wheat bran, psyllium, colorectal cancer risk
- MeSH terms
- Dietary Fiber, Humans, Psyllium, Inflammatory Bowel Diseases, Prebiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
